Dermata Therapeutics Warrant Stock Buy Hold or Sell Recommendation
| DRMAW Stock | USD 0.03 0.01 26.20% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Dermata Therapeutics Warrant is 'Not Rated'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Dermata Therapeutics Warrant given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Dermata Therapeutics Warrant, the advice is generated through an automated system that utilizes algorithms and statistical models.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. Note, we conduct extensive research on individual companies such as Dermata and provide practical buy, sell, or hold advice based on investors' constraints. Dermata Therapeutics Warrant. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Execute Dermata Therapeutics Buy or Sell Advice
The Dermata recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Dermata Therapeutics Warrant. Macroaxis does not own or have any residual interests in Dermata Therapeutics Warrant or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Dermata Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Dermata Therapeutics Trading Alerts and Improvement Suggestions
| Dermata Therapeutics is not yet fully synchronised with the market data | |
| Dermata Therapeutics is way too risky over 90 days horizon | |
| Dermata Therapeutics has some characteristics of a very speculative penny stock | |
| Dermata Therapeutics appears to be risky and price may revert if volatility continues | |
| Dermata Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (12.29 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Dermata Therapeutics generates negative cash flow from operations | |
| Dermata Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: What valuation multiples suggest for Dermata Therapeutics Inc. Equity Warrant stock - Market Risk Report Free Low Drawdown Momentum Trade Ideas - newser.com |
Dermata Therapeutics Returns Distribution Density
The distribution of Dermata Therapeutics' historical returns is an attempt to chart the uncertainty of Dermata Therapeutics' future price movements. The chart of the probability distribution of Dermata Therapeutics daily returns describes the distribution of returns around its average expected value. We use Dermata Therapeutics Warrant price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Dermata Therapeutics returns is essential to provide solid investment advice for Dermata Therapeutics.
| Mean Return | 1.41 | Value At Risk | -19.09 | Potential Upside | 29.32 | Standard Deviation | 16.31 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Dermata Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Dermata Therapeutics Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | (1.5M) | 10.3M | (4.6M) | 1.2M | (4.3M) | (4.1M) | |
| Stock Based Compensation | 0.0 | 1.9M | 930.3K | 522.1K | 657.6K | 736.3K | |
| Free Cash Flow | (4.0M) | (5.7M) | (8.8M) | (6.4M) | (11.2M) | (10.6M) | |
| Change In Working Capital | (755.8K) | 289.6K | (153.6K) | 863.7K | 466.9K | 490.2K | |
| Begin Period Cash Flow | 2.0M | 530.4K | 10.8M | 6.2M | 7.4M | 5.2M | |
| Other Cashflows From Financing Activities | 268.8K | (430K) | 287.0 | 187.0 | 1.1K | 1.1K | |
| Other Non Cash Items | (36.5K) | 14.1K | 930.3K | 369.3K | (657.0M) | (624.1M) | |
| Total Cash From Operating Activities | (4.0M) | (5.7M) | (8.8M) | (6.4M) | (11.2M) | (10.6M) | |
| Issuance Of Capital Stock | 268.8K | 16.0M | 4.3M | 5.7M | 6.9M | 7.0M | |
| Net Income | (3.2M) | (7.9M) | (9.6M) | (7.8M) | (12.3M) | (11.7M) | |
| Total Cash From Financing Activities | 2.6M | 16.0M | 4.3M | 7.6M | 6.9M | 7.7M | |
| End Period Cash Flow | 530.4K | 10.8M | 6.2M | 7.4M | 3.2M | 5.5M |
Note: Acquisition by Van Hoose Kyri K. of 78741 shares of Dermata Therapeutics subject to Rule 16b-3 [view details]
Dermata Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Dermata . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.26 | |||
| Day Median Price | 0.0289 | |||
| Day Typical Price | 0.0289 | |||
| Price Action Indicator | 0.003 | |||
| Period Momentum Indicator | 0.006 | |||
| Relative Strength Index | 55.13 |
About Dermata Therapeutics Buy or Sell Advice
When is the right time to buy or sell Dermata Therapeutics Warrant? Buying financial instruments such as Dermata Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Dermata Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Power Assets Thematic Idea Now
Power Assets
Large capitalization equities showing high long-term performance indicators and above average return expectations based on Macroaxis rating system. The Power Assets theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Power Assets Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Dermata Stock Analysis
When running Dermata Therapeutics' price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.